Medicare Enrolled
Dr. Randy Rich, MD
Hematology & Oncology · Arlington Heights, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rich from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rich?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rich
Dr. Randy Rich is a hematology & oncology specialist in Arlington Heights, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rich performed 79,339 Medicare services across 3,011 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rich received a total of $11,362 from 24 pharmaceutical and/or device companies across 76 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rich is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 14% volume in IL
$11,362 industry payments
Medicare Practice Summary
Medicare Utilization ↗79,339
Medicare services
Top 14% in IL for hematology & oncology
3,011
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,967 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
23,620 | $2 | $20 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
16,050 | $0 | $6 |
| Pembrolizumab injection (Keytruda) | 13,200 | $43 | $137 |
| Denosumab injection (Prolia/Xgeva) | 7,980 | $19 | $68 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,836 | $8 | $35 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,790 | $0 | $1 |
| Iron infusion (Monoferric) | 1,600 | $17 | $69 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,381 | $8 | $19 |
| Flow cytometry, additional marker An additional marker is tested during a flow cytometry procedure to analyze DNA or cells. This step adds specific data points to the initial analysis. |
1,247 | $19 | $144 |
| Injection, granisetron hydrochloride, 100 mcg | 1,150 | $0 | $24 |
| Injection, fulvestrant, 25 mg | 1,140 | $8 | $244 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,110 | $1 | $114 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
615 | $102 | $231 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
565 | $13 | $105 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 521 | $3 | $373 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
494 | $2 | $13 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
491 | $66 | $168 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
458 | $11 | $93 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
437 | $2 | $300 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
430 | $108 | $686 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
288 | $70 | $1,348 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
250 | $60 | $205 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
205 | $35 | $139 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
199 | $24 | $152 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
179 | $7 | $431 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
153 | $1 | $17 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
147 | $27 | $141 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
144 | $54 | $334 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
124 | $71 | $70 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
120 | $1 | $11 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
112 | $51 | $304 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
106 | $66 | $157 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
104 | $1 | $6 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
88 | $2 | $19 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
83 | $4 | $29 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
81 | $23 | $156 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
81 | $99 | $232 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
76 | $27 | $249 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 75 | $135 | $3,675 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
71 | $1 | $7 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
67 | $144 | $412 |
| New patient office visit, complex (60-74 min) | 66 | $183 | $432 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
56 | $10 | $73 |
| Injection, leucovorin calcium, per 50 mg | 54 | $3 | $25 |
| Flow cytometry DNA or cell analysis, first marker A laboratory test that uses a laser to analyze cells or DNA by detecting a specific marker on the cell surface or within the cell. |
43 | $61 | $289 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
35 | $1 | $19 |
| Injection, hydrocortisone sodium succinate, up to 100 mg | 33 | $14 | $35 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
29 | $17 | $97 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
27 | $149 | $325 |
| On-body injector for subcutaneous injection A device is applied to the skin to automatically deliver a medication injection under the skin. |
24 | $15 | $108 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
23 | $123 | $343 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
22 | $31 | $240 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
22 | $109 | $297 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
13 | $42 | $115 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
13 | $32 | $56 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
11 | $76 | $183 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.4% high complexity
88.1% medium
8.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,362
Total received (2018-2024)
Avg $1,623/year across 7 years
Top 29% in IL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
76
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$9,817 (86.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,476 (13.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$70 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$757
2023
$340
2022
$199
2021
$948
2020
$2,840
2019
$6,236
2018
$42
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Celgene Corporation
$259
Novartis Pharmaceuticals Corporation
$116
PFIZER INC.
$70
E.R. Squibb & Sons, L.L.C.
$68
ABBVIE INC.
$57
TerSera Therapeutics LLC
$30
Tempus AI, Inc
$30
SpringWorks Therapeutics, Inc.
$28
AstraZeneca Pharmaceuticals LP
$27
Daiichi Sankyo Inc.
$24
Astellas Pharma US Inc
$21
Bayer Healthcare Pharmaceuticals Inc.
$15
Deciphera Pharmaceuticals Inc.
$14
Top 3 companies account for 58.7% of 2024 payments
All-time payments by company (2018-2024) ›
Bayer HealthCare Pharmaceuticals Inc.
$7,974
Celgene Corporation
$1,255
Janssen Biotech, Inc.
$987
Novartis Pharmaceuticals Corporation
$344
PFIZER INC.
$183
ABBVIE INC.
$103
E.R. Squibb & Sons, L.L.C.
$87
AstraZeneca Pharmaceuticals LP
$50
Pharmacyclics LLC, An AbbVie Company
$45
Boehringer Ingelheim Pharmaceuticals, Inc.
$34
TerSera Therapeutics LLC
$30
Tempus AI, Inc
$30
SpringWorks Therapeutics, Inc.
$28
Pharmacyclics LLC, an AbbVie Company
$26
Daiichi Sankyo Inc.
$24
Sysmex Inostics Inc
$24
Gilead Sciences, Inc.
$23
EISAI INC.
$22
Astellas Pharma US Inc
$21
Taiho Oncology, Inc.
$18
Merck Sharp & Dohme LLC
$16
Bayer Healthcare Pharmaceuticals Inc.
$15
Deciphera Pharmaceuticals Inc.
$14
AbbVie Inc.
$11
Top 3 companies account for 89.9% of all-time payments
Associated products mentioned in payments ›
BOSULIF · ELIQUIS · ERLEADA · Erleada · GILOTRIF · IMBRUVICA · IMFINZI · KEYTRUDA · KISQALI · LYNPARZA · Lenvima · Lonsurf · MYLOTARG · Nubeqa · OGSIVEO · OPDIVO · OPDUALAG · PIQRAY · PROMACTA · Padcev · Pomalyst · QINLOCK · REBLOZYL · SCEMBLIX · Stivarga · TASIGNA · VENCLEXTA · Vanflyta · XALKORI · Xofigo · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (86%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
Hematology & oncology specialists within 10 mi
278
Per 100K population
5.4
County median income
$81,797
Nearest hospital
NORTHWEST COMMUNITY HOSPITAL 1
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rich is a mixed practice specialist, with above-average Medicare volume (top 14% in IL), with consulting-driven industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rich experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Rich performed 23,620 darbepoetin injection (aranesp) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rich receive payments from pharmaceutical companies?
Yes. Dr. Rich received a total of $11,362 from 24 companies across 76 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rich's costs compare to other hematology & oncology specialists in Arlington Heights?
Dr. Rich's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rich) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Arlington Heights
Browse hematology & oncology specialists in Arlington Heights ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in IL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in IL
Which IL hematology & oncology specialists receive the most from drug and device companies.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology